Berna C. Ozdemir - Lausanne University Hospital, University of Lausanne

基本信息

Career Trajectory

Bio

My clinical focus are precision oncology and immunooncology and the impact on sex and ethnicity on cancer incidence and mortality. I am currently comparing different next generation sequencing (NGS) panels for their clinical utility and investigating sex differences in toxicity and efficacity of anticancer therapies.

Research Interests

Papers共 73 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Gender Differences in Melanoma Awareness, Diagnosis and Treatment: Patient‐reported Data from a Multicentre Survey in Switzerland

Johanna Mangana, Cristina Lamos,Berna C Özdemir,Heinz Läubli, Linda Morgan,Lara V Maul,David König,Florentia Dimitriou, Sandra Kaiser, Janine Landolt, Anastasia Musiari, Nadine Pasche,Beat Siegenthaler,Reinhard Dummer,Valerio Del Prete

Skin health and diseaseno. 6 (2024): e442-e442

Cited0Views0WOSBibtex

Successful Treatment of Immune Checkpoint Inhibitor-Related Periaortitis

Elias D. Buhrer,Ian L. Alberts,Lisa Christ,Berna C. Ozdemir

Schweizerische medizinische Wochenschriftno. 2 (2024): 3631-3631

Cited0Views0WOSBibtex

Awareness of the Impact of Sex and Gender in the Disease Risk and Outcomes in Hematology and Medical Oncology-a Survey of Swiss Clinicians

Xenia Darphin,Jeanne Moor,Cristina Espinosa da Silva,Anke Richters,Berna C. Ozdemir

Cancer Reportsno. 2 (2024)

Cited0Views0WOSBibtex

Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022

Laure-Anne Teuwen, Joanna Young, Saleh Alessy,Berna C. Ozdemir,Diah Martina, Sharif Folorunso,Maria T. Bourlon,Hans Prenen,Eva Segelov

JCO GLOBAL ONCOLOGY（2024）

Cited0Views0WOSBibtex

Androgen Receptor Signalling in Non-Prostatic Malignancies: Challenges and Opportunities

G. Paolo Dotto, An Buckinx,Berna C. Özdemir,Christian Simon

Nature Reviews Cancerno. 2 (2024): 93-108

Cited0Views0WOSNATUREBibtex

1592P Awareness and Interest of Oncology Professionals in Sex and Gender Differences in Cancer Risk and Outcome: Analysis of an ESMO Gender Medicine Task Force Survey

B.C. Özdemir, A. Richters,S. Oertelt-Prigione,A.A. Adjei,S. Borchmann, J.B.A.G. Haanen,A. Letsch, A. Quaas,R.H.A. Verhoeven,A.D. Wagner

Annals of Oncology (2024): S959

Cited0Views0Bibtex

Sex Differences in the Pharmacokinetics of Anticancer Drugs: a Systematic Review

J. Delahousse,A.D. Wagner,S. Borchmann,A.A. Adjei,J. Haanen, F. Burgers,A. Letsch, A. Quaas,S. Oertelt-Prigione,B.C. Özdemir,R.H.A. Verhoeven, O. Della Pasqua,A. Paci,O. Mir

ESMO Openno. 12 (2024): 104002

Cited0Views0WOSBibtex

INCREASED AWARENESS of SEX and GENDER AS MODULATORS of CANCER RISK and OUTCOME IS REQUIRED AMONG CANCER RESEARCHERS

Berna C. Ozdemir

Journal of Research in Pharmacyno. 28_special_issue_1 (2024): 4-5

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn